|
|
||||||||
Washington University School of Medicine, St. Louis, Missouri
Correspondence: For reprints contact: T. J. Tewson, PhD, Mallinckrodt Institute of Radiology, Washington Univ. School of Medicine, 510 S. Kingshighway, St. Louis, MO 63110.
ABSTRACT
No-carrier-added [18F] fluoroethanol has been prepared by two routes. The first involves fluoride-ion displacement on
-p-toluene sulfonyl ethyl glycolate followed by reduction of the
-fluoroethyl acetate. The second involves a ring-opening reaction on glycol sulfite to give an
-fluorosulfinic acid derivative that is hydrolyzed to fluoroethanol. The specific activity was measured as 105 Ci/millimole, and the stable fluorine-19 was traced to the cesium hydroxide used to trap the H18F. Following intracarotid injection, the labeled fluoroethanol was not trapped in the brain, and thus is not a microsphere analog as has been suggested. Tomographic images of the myocardium were obtained using the fluoroethanol as a tracer.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |